Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Claremont BioSolutions in April, 2019 for $299,988.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA239967-01 | Phase I | 299,988 | April 3, 2019 | |||||||
A SBIR Phase I contract was awarded to Claremont BioSolutions in September, 2018 for $197,365.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM131530-01 | Phase I | 197,365 | September 15, 2018 | |||||||
A SBIR Phase II contract was awarded to Claremont BioSolutions in May, 2021 for $1,164,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM131530-02A1 | Phase II | 1,164,571 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Claremont BioSolutions in September, 2014 for $691,509.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109502-01 | Phase I | 691,509 | September 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Claremont BioSolutions for $3,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI078619-03 | Phase II | 3,000,000 | ||||||||
A SBIR Phase I contract was awarded to Claremont BioSolutions for $609,306.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI078619-01A2 | Phase I | 609,306 |